Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in adults with non-segmental vitiligo
jRCT2031210234Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in Vitiligo comparing Upadacitinib oral tablet with Placebo oral tablet (2 arms). Primary endpoint: Percent change from baseline in Facial Vitiligo Area Scoring Index. Started Aug 2021; status: active, not recruiting.
02
Drugs
upadacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on jRCT2031210234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210234.